Concepedia

Publication | Open Access

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes

DOIFull Paper Access

33

Citations

27

References

2004

Year

Mette Zander, Allan Christiansen, Sten Madsbad, Jens J. Holst
Diabetes Care

Abstract

GLP-1 and pioglitazone show an additive glucose-lowering effect. A combination of the two agents may, therefore, be a valuable therapeutic approach for the treatment of type 2 diabetes.

References

YearCitations

Page 1